NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,159 | -32.3% | 21,395 | -11.6% | 0.00% | -50.0% |
| Q2 2023 | $388,910 | +15.1% | 24,201 | +245.8% | 0.00% | 0.0% |
| Q3 2021 | $338,000 | +7.0% | 6,998 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $316,000 | -62.2% | 6,998 | -59.6% | 0.00% | -75.0% |
| Q1 2021 | $836,000 | -76.4% | 17,328 | -73.7% | 0.00% | -73.3% |
| Q4 2020 | $3,548,000 | +29.2% | 65,899 | -11.5% | 0.02% | +15.4% |
| Q3 2020 | $2,746,000 | +13.1% | 74,439 | -5.1% | 0.01% | +8.3% |
| Q2 2020 | $2,429,000 | +8.0% | 78,399 | -3.8% | 0.01% | -14.3% |
| Q1 2020 | $2,249,000 | -13.3% | 81,474 | -8.2% | 0.01% | +7.7% |
| Q4 2019 | $2,595,000 | +3.1% | 88,729 | -32.6% | 0.01% | -7.1% |
| Q3 2019 | $2,518,000 | -13.7% | 131,671 | -1.0% | 0.01% | -12.5% |
| Q2 2019 | $2,917,000 | +331.5% | 132,946 | +302.6% | 0.02% | +300.0% |
| Q1 2019 | $676,000 | -16.4% | 33,019 | -48.5% | 0.00% | -20.0% |
| Q4 2018 | $809,000 | +6.0% | 64,134 | +29.0% | 0.01% | +25.0% |
| Q3 2018 | $763,000 | – | 49,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |